NGS Sample Preparation Market by Product, Workflow, Technology, Application, End-User - Russia Ukraine Conflict and High Inflation

Description

List of Tables

The Global NGS Sample Preparation Market is forecasted to grow significantly, with a projected USD 2,407.06 million in 2023 at a CAGR of 15.93% and expected to reach a staggering USD 6,807.76 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global NGS Sample Preparation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global NGS Sample Preparation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Reagents & Consumables and Workstations. The Reagents & Consumables commanded largest market share of 64.72% in 2022, followed by Workstations.

Based on Workflow, market is studied across DNA, Library Preparation, Quality Control, RNA, and Target Enrichment. The DNA is further studied across Human Whole Genome Sequencing (WGS), Targeted Sequencing, and Whole Exome Sequencing (WES). The RNA is further studied across Gene Expression Analysis and Whole Transcriptome Sequencing. The Target Enrichment is further studied across Targeted Seq, WES, and Whole Exome Sequencing (WES). The DNA commanded largest market share of 24.92% in 2022, followed by RNA.

Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis (SBS), and Single-molecule real-time (SMRT) Sequencing. The Ion Semiconductor Sequencing commanded largest market share of 30.57% in 2022, followed by Single-molecule real-time (SMRT) Sequencing.

Based on Application, market is studied across Agricultural & Animal Research, Disease Diagnostics, and Drug Discovery. The Disease Diagnostics is further studied across Cancer Diagnostics, Infectious Disease Diagnostics, and Reproductive Health Diagnostics. The Drug Discovery commanded largest market share of 39.94% in 2022, followed by Disease Diagnostics.

Based on End-User, market is studied across Academic Institutes and Research Centers, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 49.04% in 2022, followed by Hospitals & Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.81% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global NGS Sample Preparation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global NGS Sample Preparation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global NGS Sample Preparation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global NGS Sample Preparation Market?

4. What is the competitive strategic window for opportunities in the Global NGS Sample Preparation Market?

5. What are the technology trends and regulatory frameworks in the Global NGS Sample Preparation Market?

6. What is the market share of the leading vendors in the Global NGS Sample Preparation Market?

7. What modes and strategic moves are considered suitable for entering the Global NGS Sample Preparation Market?

Product Code: MRR-9F52358C4188

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. NGS Sample Preparation Market, by Product, 2022 vs 2030
4.3. NGS Sample Preparation Market, by Workflow, 2022 vs 2030
4.4. NGS Sample Preparation Market, by Technology, 2022 vs 2030
4.5. NGS Sample Preparation Market, by Application, 2022 vs 2030
4.6. NGS Sample Preparation Market, by End-User, 2022 vs 2030
4.7. NGS Sample Preparation Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
  - 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
  - 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
- 5.1.2. Restraints
  - 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancement in NGS sample preparation platforms
  - 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
- 5.1.4. Challenges
  - 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. NGS Sample Preparation Market, by Product

6.1. Introduction
6.2. Reagents & Consumables
6.3. Workstations

7. NGS Sample Preparation Market, by Workflow

7.1. Introduction
7.2. DNA
- 7.2.1. Human Whole Genome Sequencing (WGS)
- 7.2.2. Targeted Sequencing
- 7.2.3. Whole Exome Sequencing (WES)
7.3. Library Preparation
7.4. Quality Control
7.5. RNA
- 7.5.1. Gene Expression Analysis
- 7.5.2. Whole Transcriptome Sequencing
7.6. Target Enrichment
- 7.6.1. Targeted Seq
- 7.6.2. WES
- 7.6.3. Whole Exome Sequencing (WES)

8. NGS Sample Preparation Market, by Technology

8.1. Introduction
8.2. Ion Semiconductor Sequencing
8.3. Nanopore Sequencing
8.4. Sequencing by Synthesis (SBS)
8.5. Single-molecule real-time (SMRT) Sequencing

9. NGS Sample Preparation Market, by Application

9.1. Introduction
9.2. Agricultural & Animal Research
9.3. Disease Diagnostics
- 9.3.1. Cancer Diagnostics
- 9.3.2. Infectious Disease Diagnostics
- 9.3.3. Reproductive Health Diagnostics
9.4. Drug Discovery

10. NGS Sample Preparation Market, by End-User

10.1. Introduction
10.2. Academic Institutes and Research Centers
10.3. Hospitals & Clinics
10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Sample Preparation Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific NGS Sample Preparation Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa NGS Sample Preparation Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
- 14.3.1. Merger & Acquisition
  - 14.3.1.1. INTEGRA Biosciences Acquires Miroculus
  - 14.3.1.2. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
  - 14.3.1.3. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
- 14.3.2. Agreement, Collaboration, & Partnership
  - 14.3.2.1. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
  - 14.3.2.2. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
- 14.3.3. New Product Launch & Enhancement
  - 14.3.3.1. Agilent enhances user experience in NGS sample preparation workflow
  - 14.3.3.2. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
  - 14.3.3.3. NGS KAPA Target Enrichment Product Launch
  - 14.3.3.4. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
  - 14.3.3.5. Introducing Tecan's MagicPrep NGS - the walkaway solution for your NGS library prep needs

15. List of Company Mentioned

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

1. Agilent Technologies, Inc.

2. Applied Biological Materials Inc.

3. Aurora Biomed Inc.

4. Beckman Coulter by Danaher Corporation

5. BGI Group

6. Bio-Rad Laboratories, Inc.

7. BioDynami

8. Eppendorf SE

9. Eurofins Genomics LLC

10. F. Hoffmann-La Roche Ltd.

11. FORMULATRIX, Inc.

12. Illumina, Inc.

13. Integrated DNA Technologies, Inc.

14. Macrogen Inc.

15. Magen Biotechnology Co., Ltd.

16. MCLAB

17. Merck KGaA

18. New England Biolabs, Inc.

19. Novogene Co., Ltd.

20. Oxford Nanopore Technologies PLC

21. PerkinElmer Inc.

22. Promega Corporation

23. Psomagen, Inc.

24. Qiagen N.V.

25. SPT Labtech Ltd

26. Standard BioTools Inc.

27. Sysmex Corporation

28. Takara Bio Inc.

29. Tecan Trading AG

30. Thermo Fisher Scientific Inc.

31. Twist Bioscience Corporation

32. Zymo Research Corporation